Refined mapping of X-linked reticulate pigmentary disorder and sequencing of candidate genes

[1]  J. Gécz,et al.  Mutations in the gene encoding the Sigma 2 subunit of the adaptor protein 1 complex, AP1S2, cause X-linked mental retardation. , 2006, American journal of human genetics.

[2]  P. Tarpey,et al.  The genetics of mental retardation. , 2006, Human molecular genetics.

[3]  J. Harley,et al.  Localization and replication of the systemic lupus erythematosus linkage signal at 4p16: interaction with 2p11, 12q24 and 19q13 in European Americans , 2006, Human Genetics.

[4]  A. Zinn,et al.  X‐linked Reticulate Pigmentary Disorder with Systemic Manifestations: Report of a Third Family and Literature Review , 2005, Pediatric dermatology.

[5]  L. Alhonen,et al.  Disturbed keratinocyte differentiation in transgenic mice and organotypic keratinocyte cultures as a result of spermidine/spermine N-acetyltransferase overexpression. , 2005, The Journal of investigative dermatology.

[6]  E. Bertrand,et al.  Human Box H/ACA Pseudouridylation Guide RNA Machinery , 2004, Molecular and Cellular Biology.

[7]  C. Skinner,et al.  X-linked spermine synthase gene (SMS) defect: the first polyamine deficiency syndrome , 2003, European Journal of Human Genetics.

[8]  R. Ravazzolo,et al.  Gene dosage of the spermidine/spermine N1-acetyltransferase (SSAT) gene with putrescine accumulation in a patient with a Xp21.1p22.12 duplication and keratosis follicularis spinulosa decalvans (KFSD) , 2002, Human Genetics.

[9]  Warren C. Lathe,et al.  Prediction of deleterious human alleles. , 2001, Human molecular genetics.

[10]  S. Klauck,et al.  Genomic rearrangement in NEMO impairs NF-κB activation and is a cause of incontinentia pigmenti , 2000, Nature.

[11]  K. Collins,et al.  A telomerase component is defective in the human disease dyskeratosis congenita , 1999, Nature.

[12]  Michael Ruogu Zhang,et al.  Statistical features of human exons and their flanking regions. , 1998, Human molecular genetics.

[13]  K. Jeang,et al.  Regulatory Role for a Novel Human Thioredoxin Peroxidase in NF-κB Activation* , 1997, The Journal of Biological Chemistry.

[14]  D. Tollervey,et al.  Function and synthesis of small nucleolar RNAs. , 1997, Current opinion in cell biology.

[15]  A. Donnelly,et al.  Localisation of the gene for X-linked reticulate pigmentary disorder with systemic manifestations (PDR), previously known as X-linked cutaneous amyloidosis. , 1994, American journal of medical genetics.

[16]  D. Sillence,et al.  An X‐Linked Reticulate Pigmentary Disorder With Systemic Manifestations: Report of a Second Family , 1993, Pediatric dermatology.

[17]  E. Chouery,et al.  X-linked reticulate pigmentary layer. Report of a new patient and demonstration of a skewed X-inactivation. , 2005, Genetic counseling.

[18]  G. Abecasis,et al.  Merlin—rapid analysis of dense genetic maps using sparse gene flow trees , 2002, Nature Genetics.

[19]  S. Klauck,et al.  Genomic rearrangement in NEMO impairs NF-kappaB activation and is a cause of incontinentia pigmenti. The International Incontinentia Pigmenti (IP) Consortium. , 2000, Nature.

[20]  K. Jeang,et al.  Regulatory role for a novel human thioredoxin peroxidase in NF-kappaB activation. , 1997, The Journal of biological chemistry.

[21]  M. Partington,et al.  X-linked cutaneous amyloidosis: further clinical and pathological observations. , 1989, American journal of medical genetics.

[22]  N. Simpson,et al.  Familial cutaneous amyloidosis with systemic manifestations in males. , 1981, American journal of medical genetics.